Ledger.Open graph →
SEC Form D · filed December 23, 2020

RedShift BioAnalytics, Inc

Offering
$6.4M
Sold
$6.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BURLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

William Cadogan · Burlington, MADirectorFrank Smith · BOCA RATON, FLDirectorCharles Purtell · Burlington, MADirectorJulien Bradley · Burlington, MAExec · DirectorBryson Hollimon · Minneapolis, MNDirectorRob Carson · Burlington, MADirectorCharles Purtell · Burlington, MADirectorWilliam Cadogan · Burlington, MADirectorFrank Smith · BOCA RATON, FLDirectorJulien Bradley · Burlington, MAExec · DirectorBryson Hollimon · Minneapolis, MNDirectorRob Carson · Burlington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗